Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2008 Feb 23

PMID 18293062

Citations 17

Authors

Stuart T Charlton

Joanne Whetstone

Susan T Fayinka

Kevin D Read

Lisbeth Illum

Stanley S Davis

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to investigate and quantify drug movement to the brain via the neuro-olfactory system after intranasal dosing of four model drugs; three glycine receptor antagonists and one angiotensin antagonist.

Methods: The drugs were dosed to rats via intranasal or intravenous administration, after which a quantitative method for tissue distribution was utilised to determine drug distribution to the olfactory lobes, brain sections and the blood over 30 min. Autoradiography was used to visualise and quantify drug distribution throughout the brain and in the CSF. Micro-autoradiography was used to examine drug distribution throughout the olfactory nerve apparatus.

Results: The three glycine receptor antagonist compounds were transported to the CNS to differing degrees although they had similar molecular structures and similar physicochemical characteristics. All three compounds were shown to exploit a direct route of transport from nose to brain with Direct Transport Percentages (DTP) of 99.99%, 96.71% and 51.95%, respectively, although for the last molecule a major part of the brain content originated from systemic transport across the BBB. Intranasal administration of GR138950 resulted in over 3.5 times more drug in the olfactory lobes at 1 min post-dose compared to intravenous administration; and 5 times more drug was delivered to the olfactory lobes over 30 min. Micro-autoradiography showed that GR138950 could be found throughout the olfactory nerve apparatus. Autoradiography illustrated drug distribution throughout the brain and CSF, with drug concentrations in the CSF being equal or higher than in the brain tissue. It was determined that approximately 0.8% of the administered dose moved into the brain and CSF via the olfactory pathway over 30 min.

Conclusions: Intranasal administration resulted in greater delivery of the model drugs to the olfactory lobes and brain as compared to intravenous dosing. It is proposed that the drug moved through the neuro-olfactory system, primarily via paracellular pathways.

Citing Articles

An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway.

Zeng H, Lu H, Yang J, Hu P Pharm Res. 2024; 41(11):2121-2141.

PMID: 39477900 DOI: 10.1007/s11095-024-03790-3.

Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes.

Petkova A, Kubajewska I, Vaideanu A, Schatzlein A, Uchegbu I Pharmaceutics. 2022; 14(6).

PMID: 35745709 PMC: 9231247. DOI: 10.3390/pharmaceutics14061136.

The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid.

von Bohlen Und Halbach O Histol Histopathol. 2021; 36(11):1125-1131.

PMID: 34142714 DOI: 10.14670/HH-18-356.

Biomaterials for Drugs Nose-Brain Transport: A New Therapeutic Approach for Neurological Diseases.

Cassano R, Servidio C, Trombino S Materials (Basel). 2021; 14(7).

PMID: 33917404 PMC: 8038678. DOI: 10.3390/ma14071802.

Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children.

Chen H, Yang F, Ye M, Liu H, Zhang J, Tian Q BMC Anesthesiol. 2020; 20(1):61.

PMID: 32145737 PMC: 7060610. DOI: 10.1186/s12871-020-00978-z.

References

van den Berg M, Merkus P, Romeijn S, Verhoef J, Merkus F . Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans. J Drug Target. 2003; 11(6):325-31. DOI: 10.1080/10611860310001640075. View

Fisher A, Brown K, Davis S, Parr G, Smith D . The nasal absorption of sodium cromoglycate in the albino rat. J Pharm Pharmacol. 1985; 37(1):38-41. DOI: 10.1111/j.2042-7158.1985.tb04927.x. View

Sakane T, Akizuki M, Taki Y, Yamashita S, Sezaki H, NADAI T . Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J Pharm Pharmacol. 1995; 47(5):379-81. DOI: 10.1111/j.2042-7158.1995.tb05814.x. View

Pardridge . Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems. Pharm Sci Technol Today. 1999; 2(2):49-59. DOI: 10.1016/s1461-5347(98)00117-5. View

Charlton S, Davis S, Illum L . Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems. Int J Pharm. 2007; 338(1-2):94-103. DOI: 10.1016/j.ijpharm.2007.01.047. View

Thorne R, Pronk G, Padmanabhan V, Frey 2nd W . Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004; 127(2):481-96. DOI: 10.1016/j.neuroscience.2004.05.029. View

Illum L . Is nose-to-brain transport of drugs in man a reality?. J Pharm Pharmacol. 2004; 56(1):3-17. DOI: 10.1211/0022357022539. View

Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z . Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm. 2004; 275(1-2):85-96. DOI: 10.1016/j.ijpharm.2004.01.039. View

JUDD D, Dowle M, Middlemiss D, Scopes D, Ross B, Jack T . Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability. J Med Chem. 1994; 37(19):3108-20. DOI: 10.1021/jm00045a016. View

10.

Boek W, Graamans K, Huizing E . Ciliary beat frequency of human sphenoid sinus mucosa after cryopreservation. Eur Arch Otorhinolaryngol. 1998; 255(3):135-7. DOI: 10.1007/s004050050029. View

11.

Remigius U, Jorissen M, Willems T, Kinget R, Verbeke N . Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium. Eur J Pharm Biopharm. 2003; 55(3):283-9. DOI: 10.1016/s0939-6411(03)00023-7. View

12.

Eriksson C, Bergman U, Franzen A, Sjoblom M, Brittebo E . Transfer of some carboxylic acids in the olfactory system following intranasal administration. J Drug Target. 2000; 7(2):131-42. DOI: 10.3109/10611869909085497. View

13.

Dahlin M, Bergman U, Jansson B, Bjork E, Brittebo E . Transfer of dopamine in the olfactory pathway following nasal administration in mice. Pharm Res. 2000; 17(6):737-42. DOI: 10.1023/a:1007542618378. View

14.

Sakane T, Akizuki M, Yamashita S, Sezaki H, NADAI T . Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug. J Pharm Pharmacol. 1994; 46(5):378-9. DOI: 10.1111/j.2042-7158.1994.tb03817.x. View

15.

Kleinsasser N, Juchhoff J, Wallner B, Bergner A, Harreus U, Gamarra F . The use of mini-organ cultures of human upper aerodigestive tract epithelia in ecogenotoxicology. Mutat Res. 2004; 561(1-2):63-73. DOI: 10.1016/j.mrgentox.2004.03.013. View